Panel: From Reactive to Predictive: Manufacturing Intelligence in Biologics Production

Biologics manufacturing is moving beyond deviation management and post-event troubleshooting toward predictive, intelligence-driven operations. Advances in real-time monitoring, advanced analytics, and AI-enabled process control are enabling earlier risk detection, tighter process consistency, and improved yield performance.

Yet adoption remains uneven. While leading manufacturers are embedding predictive capabilities across development and commercial production, others face barriers around validation standards, data integration, legacy infrastructure, and workforce readiness. The result is a widening operational divide between early adopters and traditional operators.

This panel will examine whether predictive manufacturing is becoming a competitive necessity rather than a digital aspiration, and what it truly takes to implement it at scale